Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04325386 · ClinicalTrials.gov registry record · NA
Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.
A NA study of Schizophrenia Schizoaffective, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 1
- Study location
NCT04325386 is a NA study of Schizophrenia Schizoaffective that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 266 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04325386, a NA study of Schizophrenia Schizoaffective, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 1
- Study location
Study Summary
In a randomized controlled design with approximately 26 biweekly sessions over 12 months, the investigators propose to test the effectiveness of an ECHO-based intervention for improving the use of clozapine in people eligible for clozapine. The sessions will include: 1) active dissemination of knowledge and information by an expert "hub" followed by 2) clozapine case presentations and vignettes submitted by the "spokes". This intervention, Clozapine CHAMPION-ECHO (Center for Help and Assistance for Maryland Prescribers- Improving Outcomes Network using Extension for Community Healthcare Outcomes, will be referred to as "CHAMPION" throughout.. To minimize ANC monitoring barriers and maximize recruitment, the investigators will provide Food and Drug Administration (FDA)-cleared ANC point of care (POC) monitoring devices to all study sites, including those in the control condition. The investigators will enroll at least 300 prescribers and additional clinical team members (up to 300) from up to 60 mental health clinics (MHCs) and other treatment sites; approximately half the participants will be randomized to CHAMPION and half randomized to enhanced treatment as usual (ETAU).
Conditions Studied
Interventions
- OTHER ECHO Intervention
- OTHER eTAU
Study Locations (1)
Maryland
- Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP) - Catonsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2024-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04325386
The ClinicalTrials.gov registry entry for NCT04325386 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Schizophrenia Schizoaffective appearing as the primary indexed condition, and to 2 interventions - of which ECHO Intervention is the first listed.
NCT04325386 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04325386 about?
NCT04325386 is a clinical study titled "Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.". In a randomized controlled design with approximately 26 biweekly sessions over 12 months, the investigators propose to test the effectiveness of an ECHO-based intervention for improving the use of clozapine in people eligible for clozapine. The sessions will include: 1) active dissemination of knowl...
What is the current status of trial NCT04325386?
This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2020-02-01. Estimated completion is 2024-09-20.
What conditions does trial NCT04325386 study?
This clinical trial studies the following conditions: Schizophrenia Schizoaffective.
What interventions are being tested in trial NCT04325386?
The interventions under investigation include: ECHO Intervention (OTHER), eTAU (OTHER).
Who is sponsoring clinical trial NCT04325386?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04325386 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia Schizoaffective
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.